Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Nutting

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2010
Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancersKevin J Harrington, Eleni M Karapanagiotou, Victoria Roulstone, et al.
The Lancet. Oncology|January 18, 2011
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialChristopher M Nutting, James P Morden, Kevin J Harrington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factorJennifer C C Hu, Robert S Coffin, Ceri J Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2017
Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRIRafal Panek, Liam Welsh, Lauren C J Baker, et al.
Lancet (London, England)|March 24, 2026
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trialDavid J Thomson, James M Price, Matthew Tyler, et al.
The New England Journal of Medicine|May 4, 2012
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancerUjjal Mallick, Clive Harmer, Beng Yap, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2021
Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trialChristopher M Nutting, Clare L Griffin, Paul Sanghera, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2018
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)Christopher M Nutting, James P Morden, Matthew Beasley, et al.
Cancer Research|August 30, 2016
HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease EtiologyAndrew G Schache, Ned G Powell, Kate S Cuschieri, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2010
Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancersKevin J Harrington, Eleni M Karapanagiotou, Victoria Roulstone, et al.
The Lancet. Oncology|January 18, 2011
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialChristopher M Nutting, James P Morden, Kevin J Harrington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factorJennifer C C Hu, Robert S Coffin, Ceri J Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2017
Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRIRafal Panek, Liam Welsh, Lauren C J Baker, et al.
Lancet (London, England)|March 24, 2026
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trialDavid J Thomson, James M Price, Matthew Tyler, et al.
The New England Journal of Medicine|May 4, 2012
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancerUjjal Mallick, Clive Harmer, Beng Yap, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2021
Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trialChristopher M Nutting, Clare L Griffin, Paul Sanghera, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2018
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)Christopher M Nutting, James P Morden, Matthew Beasley, et al.
Cancer Research|August 30, 2016
HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease EtiologyAndrew G Schache, Ned G Powell, Kate S Cuschieri, et al.
Pageof 11